These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 37530504)

  • 1. Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis.
    Shinogi Y; Hirai T; Ishibashi M; Ino K; Tawara I; Iwamoto T
    Pharmacol Res Perspect; 2023 Aug; 11(4):e01120. PubMed ID: 37530504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal.
    Nakashima T; Inamoto Y; Aoki J; Ito A; Tanaka T; Kim SW; Hashimoto H; Fukuda T; Furukawa T
    Int J Hematol; 2022 Feb; 115(2):158-162. PubMed ID: 35088349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Peksa GD; Schultz K; Fung HC
    J Oncol Pharm Pract; 2015 Dec; 21(6):409-15. PubMed ID: 24938293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letermovir and tacrolimus interaction effects in hematopoietic cell transplantation recipients receiving moderate cytochrome P450 3A4 inhibitors for antifungal prophylaxis.
    Malespini J; Lei M; Tavares E; Hammond SP; Chen YB; Luk SO; DeFilipp Z
    J Oncol Pharm Pract; 2023 Oct; 29(7):1574-1579. PubMed ID: 36398324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals.
    Atiq F; Hameli E; Broers AEC; Doorduijn JK; Van Gelder T; Andrews LM; Koch BCP; Versmissen J; de Winter BCM
    Eur J Clin Pharmacol; 2018 Jun; 74(6):767-773. PubMed ID: 29500599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of letermovir initiation on tacrolimus concentrations among lung transplant recipients receiving concomitant azole antifungal prophylaxis.
    Goodlet KJ; Garcia R
    Transpl Infect Dis; 2024 Apr; 26(2):e14267. PubMed ID: 38488776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
    Marshall WL; McCrea JB; Macha S; Menzel K; Liu F; van Schanke A; de Haes JIU; Hussaini A; Jordan HR; Drexel M; Kantesaria BS; Tsai C; Cho CR; Hulskotte EGJ; Butterton JR; Iwamoto M
    J Clin Pharmacol; 2018 Jul; 58(7):897-904. PubMed ID: 29578577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study.
    Hikasa S; Shimabukuro S; Osugi Y; Ikegame K; Kaida K; Fukunaga K; Higami T; Tada M; Tanaka K; Yanai M; Kimura T
    Int J Med Sci; 2020; 17(7):859-864. PubMed ID: 32308538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
    Yamashita T; Fujishima N; Miura M; Niioka T; Abumiya M; Shinohara Y; Ubukawa K; Nara M; Fujishima M; Kameoka Y; Tagawa H; Hirokawa M; Takahashi N
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):111-8. PubMed ID: 27217047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of drug and food interactions with azole antifungal agents in transplant recipients.
    Dodds-Ashley E
    Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Infusion of Fentanyl Has No Effect on Blood Concentration of Tacrolimus in Patients Receiving Hematopoietic Stem-Cell Transplantation.
    Ishiwata Y; Nagata M; Kiuchi S; Ippongi C; Takeda H; Takahashi H
    Ther Drug Monit; 2021 Oct; 43(5):688-691. PubMed ID: 33298744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation.
    Mahnke CB; Sutton RM; Venkataramanan R; Michaels M; Kurland G; Boyle GJ; Law YM; Miller SA; Pigula FA; Gandhi S; Webber SA
    Pediatr Transplant; 2003 Dec; 7(6):474-8. PubMed ID: 14870897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Pharmacokinetic Interaction Between Letermovir and Tacrolimus in Allogeneic Hematopoietic Cell Transplantation Recipients.
    Marciano KA; Seago K; Dillaman M; Ross KG; Veltri L; Cumpston A
    Transplant Cell Ther; 2022 Jul; 28(7):371.e1-371.e4. PubMed ID: 35405369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
    Gu TM; Lewis JS; Le H; Bubalo JS
    J Oncol Pharm Pract; 2022 Sep; 28(6):1357-1362. PubMed ID: 34192963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series.
    Griffin SP; Lee B; Doh J; Paradyse AR; Jeyakumar D; Arter Z; Nam H; Blodget E; Smith J; Valek A; Vittayawacharin P; Kongtim P; Ciurea SO
    Acta Haematol; 2023 Oct; ():1-7. PubMed ID: 38059378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
    McCrea JB; Macha S; Adedoyin A; Marshall W; Menzel K; Cho CR; Liu F; Zhao T; Levine V; Kraft WK; Yoon E; Panebianco D; Stoch SA; Iwamoto M
    J Clin Pharmacol; 2019 Oct; 59(10):1331-1339. PubMed ID: 30990905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluconazole on the pharmacokinetics of everolimus and tacrolimus in a heart transplant recipient: Case report.
    Nakagita K; Wada K; Terada Y; Matsuda S; Terakawa N; Oita A; Takada M
    Int J Clin Pharmacol Ther; 2018 Jun; 56(6):270-276. PubMed ID: 29648533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.
    Goyal RK; Han K; Wall DA; Pulsipher MA; Bunin N; Grupp SA; Mada SR; Venkataramanan R
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):569-75. PubMed ID: 23266742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole.
    Mihara A; Mori T; Aisa Y; Yamazaki R; Iketani O; Tanigawara Y; Ikeda Y; Okamoto S
    Eur J Clin Pharmacol; 2008 Jan; 64(1):89-91. PubMed ID: 17965855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.